Race-Related disparities in COVID-19 thrombotic outcomes: Beyond social and economic explanations

Simple item page
dc.contributor.authorChaudhary, Rahul
dc.contributor.authorBliden, Kevin P.
dc.contributor.authorKreutz, Rolf P.
dc.contributor.authorJeong, Young-Hoon
dc.contributor.authorTantry, Udaya S.
dc.contributor.authorLevy, Jerrold H.
dc.contributor.authorGurbel, Paul A.
dc.contributor.departmentMedicine, School of Medicineen_US
dc.date.accessioned2021-01-25T20:13:46Z
dc.date.available2021-01-25T20:13:46Z
dc.date.issued2020-11-20
dc.description.abstractAfrican Americans (AAs) have worse COVID-19-related outcomes than Caucasians and Asians, a disparity currently attributed to potential social and economic factors. In this commentary, we endeavor to examine important race-related differences in intrinsic thrombogenicity as another significant contributing factor and propose objective hemostasis assessments to address racial disparities in COVID-19 outcomes.en_US
dc.description.sponsorshipFunding: Platelet and Thrombosis Research, LLC. Competing Interest: Dr. Kreutz has received consulting fees from Haemonetics. Dr. Jeong has received honoraria for lectures from AstraZeneca, Sanofi-Aventis, Daiichi Sankyo/Lilly, Haemonetics, Otsuka, Han-mi Pharmaceuticals and Yuhan Pharmaceuticals; and research grants or support from AstraZeneca, Korean Society of Interventional Cardiology, Han-mi Pharmaceuticals, Yuhan Pharmaceuticals, Otsuka and Haemonetics. Dr. Levy reports honoraria for advisory boards from Instrumentation Labs, Merck, Octapharma, and Janssen. Dr. Gurbel reports grants and personal fees from Bayer HealthCare LLC, Otitopic Inc, Amgen, Janssen, and US WorldMeds LLC; grants from Instrumentation Laboratory, Haemonetics, Medicure Inc, Idorsia Pharmaceuticals, and Hikari Dx; personal fees from UpToDate; Dr Gurbel is a relator and expert witness in litigation involving clopidogrel; in addition, Dr. Gurbel has two patents, Detection of restenosis risk in patients and Assessment of cardiac health and thrombotic risk in a patient. Other authors report no disclosure.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationChaudhary, R., Bliden, K. P., Kreutz, R. P., Jeong, Y.-H., Tantry, U. S., Levy, J. H., & Gurbel, P. A. (2020). Race-Related disparities in COVID-19 thrombotic outcomes: Beyond social and economic explanations. EClinicalMedicine, 29. https://doi.org/10.1016/j.eclinm.2020.100647en_US
dc.identifier.issn2589-5370en_US
dc.identifier.urihttps://hdl.handle.net/1805/24974
dc.language.isoen_USen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1016/j.eclinm.2020.100647en_US
dc.relation.journalEClinicalMedicineen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourcePublisheren_US
dc.subjectCOVID-19en_US
dc.subjectRacial Disparitiesen_US
dc.subjectThrombosisen_US
dc.subjectThrombogenicityen_US
dc.subjectRisk Factorsen_US
dc.titleRace-Related disparities in COVID-19 thrombotic outcomes: Beyond social and economic explanationsen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Chaudhary2020Race.pdf
Size:
245.93 KB
Format:
Adobe Portable Document Format
Description:
Article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Medicine Works
Open Access Coronavirus-Related Works